Treatment with Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients Induces Changes in Inflammatory Mechanism

By Ramos-Cejudo Jaime  

Journal of Clinical Immunology, Vol. 31, Iss. 4, 2011-08 ,pp. : 623-631

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Multiple Sclerosis with Anti-CD4 Monoclonal Antibody A Preliminary Report on B-F5 in 21 Patients

By Racadot E.   Rumbach L.   Bataillard M.   Galmiche J.   Henlin J-L.   Truttmann M.   Herve P.   Wijdenes J.  

Journal of Autoimmunity, Vol. 6, Iss. 6, 1993-12 ,pp. : 771-786

Academic Press

Access to resources Recommend Favorite

A Phase I Study of the Safety of Honeybee Venom Extract as a Possible Treatment for Patients with Progressive Forms of Multiple Sclerosis

By Castro Henry J.   Mendez-Inocencio Julia I.   Omidvar Berna   Omidvar Jemal   Santilli John   Nielsen H.S.   Pavot Alfred P.   Richert John R.   Bellanti Joseph A.  

Allergy and Asthma Proceedings, Vol. 26, Iss. 6, 2005-11 ,pp. : 470-476

OceanSide Publications, Inc

Access to resources Recommend Favorite

CD30 + and CD27 - lymphocytes in liver transplant: Th2 cytokine secretion

By Minguela A.   Marn L.   Toro A.   Muro M.   Ontanon J.   Alemany J.M.   Sanchez-Bueno F.   Parrilla P.   Alvarez-Lopez M.R.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 516-518

Elsevier

Access to resources Recommend Favorite

Decreases in Interleukin-4 Secretion by Invariant CD4^-CD8^-Vα24JαQ T Cells in Peripheral Blood of Patients with Relapsing–Remitting Multiple Sclerosis

By Gausling R.   Trollmo C.   Hafler D.A.  

Clinical Immunology, Vol. 98, Iss. 1, 2001-01 ,pp. : 11-17

Academic Press

Access to resources Recommend Favorite